SecBot SecBot
SECBOTREPLAY Home › Report › VTVT

VTVT · Samsara BioCapital, L.P., a major shareholder, filed Form 144 to sell…

vTv Therapeutics Inc. · 144 filed Nov 12, 2026 at 17:59 ET

At the news

NEUTRALIMPACT 3/10

144 filed Nov 12, 2026 at 17:59 ET

Samsara BioCapital, L.P., a major shareholder, filed Form 144 to sell 61,287 shares of vTv Therapeutics common stock, with an estimated aggregate market value of approximately $1.32 million. The sale is planned for the open market, and the filing indicates the insider has considered selling a portion of its holdings.

  • Samsara BioCapital, L.P. filed Form 144 to sell 61,287 shares of vTv Therapeutics common stock.
  • Estimated aggregate market value of the proposed sale is $1,315,831.89.
  • Shares were acquired through open market purchases, a private placement, and a warrant exercise.
  • The sale is planned for the open market via Merrill Lynch.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access